Open Access

Comparison of early pregnancy serum concentration of neopterin, neopterin/creatinine ratio, C‑reactive protein, and chitotriosidase, in pregnant women with birth at term and spontaneous preterm birth

  • Authors:
    • Dan Bogdan Navolan
    • Dana Liana Stoian
    • Roxana Elena Bohiltea
    • Zorin  Crainiceanu
    • Marius Lucian Craina
    • Octavian Cretu
    • Bogdan Timar
    • Radu  Vladareanu
    • Peter Terness
    • Friederike Būrger
    • Dragos Nemescu
  • View Affiliations

  • Published online on: May 21, 2020     https://doi.org/10.3892/etm.2020.8784
  • Pages: 2449-2454
  • Copyright: © Navolan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inflammatory mechanisms are involved in achieving a normal pregnancy and in the development of certain pregnancy complications. These changes are more intense in pregnant women that suffer of pregnancy complications, such as spontaneous preterm birth (SPB). This study compared the course of inflammatory markers (IM) [neopterin (Neo), neopterin/creatinine ratio (Neo/Cre), C‑reactive protein (CRP), and chitotriosidase (Chito)] serum concentration in the early pregnancy of women with birth at term (BT) and preterm birth (PB). IM concentration was measured in 90 sera sampled from 45 pregnancies with BT and 30 sera from 15 pregnancies with PB. Two sera were sampled from each pregnant woman: one in the first trimester and another one in the second trimester. Early pregnancy IM concentration showed a direct correlation with gestational age: Neo (rho=0.262, P=0.004), Neo/Cre (rho=0.372, P<0.001), CRP (rho=0.187, P=0.041), and Chito (rho=0.039, P=0.66). The correlation was present in both categories of patients with BT and PB. Patients with PB before 34 week of pregnancy (wp) and 32 wp showed higher Neo and Neo/Cre concentration than BT patients. A significant association was found between the risk of PB before 34 wp, PB before 32 wp, and Neo concentration (PB <34 wp: odds ratio (OR) =5.13, P=0.035) (PB <32 wp: OR=8.2, P=0.020) and, respectively, Neo/Cre concentration (PB <34 wp: OR=5.29, P=0.015) (PB <32 wp: OR=9.25, P=0.006). No association between CRP or Chito and PB age was found. IM concentration correlates with the gestational age at the time of blood sampling. Increased Neo and Neo/Cre concentration are associated with PB. Further studies are needed to evaluate the usefulness of these markers in clinical practice.

Introduction

Inflammatory markers (IM) are used to monitor the course of certain diseases such as infections, autoimmune diseases, cancer, graft rejection, post surgery monitoring or hemodialysis patients (1-4). In pregnant women studies have revealed a mild increase of IM concentration and a weak activation of the cellular immune response during normal pregnancy (5,6). These changes are more intense in pregnant women that suffer of pregnancy complications, such as spontaneous preterm birth (SPB), spontaneous abortion, chorioamnionitis or preeclampsia (6-12). C-reactive protein (CRP), neopterin (Neo), and chitotriosidase (Chito) are the most studied IM in these situations (5,8).

Neo is a biomolecule synthesized by human macrophages consequent to stimulation with interferon-γ and is recognized as a marker of cellular immune system activation (13). Neo level is useful to monitor the progression of patients with graft rejection, autoimmune diseases, certain chronic diseases and infections (4,14-16). In graft recipients Neo levels increase a few days before symptoms of graft rejection complications appear (17). Also, graft recipients with a high post-surgery Neo level have a poor graft survival (18). Kidney function influences the Neo serum concentration because Neo is excreted without metabolisation via the kidney. This is why neopterin/creatinine ratio (Neo/Cre) better reflects inflammatory changes and monocyte/macrophage activation than Neo concentration alone (19).

Chito is a catabolic product of monocytes/macrophages used as a marker of macrophage activation and inflammation (20,21). Previous studies suggested that macrophages play a role in the processes of implantation and placentation (22) and in placental disorders, such as preeclampsia (23). A recent study found that pregnant women with threatened preterm labor who had preterm birth (PB) showed higher Chito serum concentrations than the ones who gave birth at term (BT) (8).

CRP is a protein that is increased in inflammation (24) and is synthesized in the liver upon stimulation with interleukin-6 (IL-6) released by macrophages and T cells (24). CRP is recognized as ‘acute phase protein’ (25). Previous studies found an association between CRP and PB, but the results were controversial (26). Keskin et al (8) did not find a difference between women with threatened PB and pregnant women with BT. In the practice CRP is used to monitor patients with premature rupture of membranes in order to capture the first biological signs of a chorioamnionitis (11,27).

Since the majority of studies analyzed the course of IM in late pregnancy (28) or at birth, only a few studies have focused on the course of IM in the first half of pregnancy. Inflammatory mechanisms seem to be involved in the achieving of a normal pregnancy and in the development of certain pregnancy complications. Because the mechanisms leading to pregnancy complications are often initiated before symptoms occur (5,29), the study of IM in early pregnancy could contribute to decoding the pathophysiological mechanisms involved in these situations and to opening the door to the development of new diagnostic tests and prevention strategies (30,31).

The worldwide incidence of PB is ~10% of all births and PB is one of the main contributors to fetal morbidity and mortality (32). Spontaneous and iatrogenic PB are different forms of PB. While iatrogenic preterm delivery is determined by a medical intervention for a maternal or fetal condition, spontaneous PB includes preterm labor, premature rupture of membranes and cervical weakness (30,31). In the clinical practice there is an acute demand to develop tests which identify pregnant women with risk of SPB at an early pregnancy age. Recognition of pregnant women at risk of premature birth could allow the implementation of preventive measures to minimize complications (31).

Starting from our previous research which revealed that Neo correlates with gestational age and predicts PB in asymptomatic pregnant women (5), we analyzed the course of other IMs (CRP, Chito, and Neo/Cre ratio) in sera consecutively collected early in pregnancy from women with BT and PB.

Patients and methods

Patients and sera

Two sera were sampled from each pregnant woman: one in the first trimester [4-13 weeks of pregnancy (wp)] and another one in the second trimester (15-22 wp). Sera were frozen at -80˚C. Medical files were analyzed retrospectively and the patients were classified according to the time of delivery (18).

Characterization of pregnant women with BT

Ninety sera were sampled from 45 pregnant women without pregnancy associated disorders and with BT: one sample in the first trimester between 4-13 wp and a second sample in the early second trimester between 15-22 wp.

Characterization of pregnant women with SPB

Thirty sera were sampled from 15 pregnant women with PB: one sample in the first trimester between 4-13 wp and a second sample in the early second trimester between 15-22 wp. Of the 15 pregnant women with PB ≤34 wp, 9 had a PB before ≤32 wp.

Detection of Neo concentration

The Neo concentration was measured using standard test kits (Neopterin EIA; Thermo Fisher Scientific, Inc.). Values are expressed in nanomoles per liter (nmol/l).

Detection of CRP and CRE concentration in sera

The CRP, concentration and CRE concentration was measured using standard test kits (FUJI DRI-Chem Slide CRP-SIII and FUJI DRI-Chem Slide CRE-SIII; Fuji Film Corporation and Nishiazabu 2-Chrome, respectively). Values are expressed in milligrams/liter (mg/l) (CRP) and milligrams per deciliter (mg/dl) (CRE).

Measurement of Chito activity in sera

Chito activity was measured by incubating 5 µl of serum with 100 µl of 0.022 mM 4-methylumbelliferyl-β-D-N,N',N''-triacetyl chitotriose (4-MU-chitotrioside; Sigma-Aldrich; Merck KGaA) as substrate in citrate/phosphate buffer (0.1/0.2 M), pH 5.2, at 37˚C for 60 min. The reaction was stopped with 120 µl of 0.5 M NaHCO3/Na2CO3 buffer, pH 10.7. Fluorescent 4-methylumbelliferone (4-MU) was measured with a fluorimeter (Infinite 200 PRO, Tecan Deutschland GmbH) with excitation at 360 nm and emission at 465 nm. The activity of Chito was calculated by using a standard curve of 4-MU with 12 different concentrations from 0-10 µM. Activities are expressed in nanomoles per milliliter per hour (nmol/ml/h).

Study design and statistical analysis

Patients were enrolled in this cohort-retrospective, non-interventional study according to a consecutive-case population base. Data were collected and analyzed using the SPSS v.17 software suite (SPSS Inc.) and since the variables were non-Gaussian distributed the results are presented as median and (interquartile range) for continuous variables, respectively, percentages and number of individuals for categorical variables. To assess the significance of the differences between groups Mann-Whitney-U test and Kruskal-Wallis (medians, non-Gaussian populations), respectively, Fisher's exact tests (proportions) were used. Continuous variable distributions were tested for normality using Shapiro-Wilk test, and for equality of variances using Levene's test.

The strength of the association between two continuous variables from non-Gaussian populations was evaluated using Spearman's correlation coefficient. Its statistical significance was assessed using t-score distribution test. Risk was assessed using the odds ratio (OR) value for dichotomous variables, respectively, by building logistic regression models for continuous variables. In these models the exponent of B was assimilated to the OR increase and is expressed for each increase with one unit in the studied parameter, in relation to the previous odds.

We did not find any statistically significant difference in gestational age at the time of sampling the sera in the studied groups: term vs. preterm, term vs. preterm ≤34 wp or term vs preterm ≤32 wp. This is why the gestational age at sampling does not significantly influence the comparison between the analysis of groups as a whole and the analysis of groups according to trimesters.

Ethical considerations

The present study meets the ethical guidelines, including adherence to the legal requirements of the study country. Informed consent was obtained from each patient. The study was approved by the Institutional Board of the ‘Victor Babes’ University of Medicine and Pharmacy (Timisoara, Romania) (approval no. 848/06.04.2011).

Results

Correlation between age of pregnancy (AOP) and IM (Neo, Neo/Cre ratio, CRP, and Chito) concentration in early pregnancy serum of women with BT and PB

We correlated AOP at the time of blood sampling (expressed in days from the last menstrual period) with IM (Neo, CRP, Chito and Neo/Cre ratio) concentration measured in 120 sera collected in the first and second trimester from 60 pregnant women. There were 90 sera collected from 45 pregnant women with BT and 30 sera from pregnant women with PB ≤34 wp, of which 18 sera were from 9 pregnant women with PB ≤32 wp. A significant correlation between AOP and Neo was present in all pregnant women (rho=0.262, P=0.004), pregnant women with BT (rho=0.204, P=0.053) and PB (rho=0.392, P=0.032), Neo/Cre ratio showed a better correlation with AOP than Neo in all pregnant women (rho=0.372, P<0.001), pregnant women with BT (rho=0.317, P=0.002) and PB (rho=0.504, P=0.004). CRP correlated with AOP in all pregnant women (rho=0.188, P=0.041), in the BT group (rho=0.192, P=0.069), but not in the PB group (rho=0.162, P=0.392). No correlation was found in early pregnancy between gestational age and Chito sera concentration in the three categories of pregnant women: all (rho=0.039, P=0.660), BT (rho=0.093, P=0.383), and PB (rho=-0.211, P=0.262).

Second trimester sera of IM concentration (Neo, Neo/Cre ratio, CRP and Chito) in pregnant women with BT, PB before 34 wp and PB before 32 wp

AOP at the time of blood sampling showed no significant difference between pregnant women with BT and PB ≤34 wp (120 vs. 119 days; P=0.822), respectively, PB ≤32 wp (120 vs. 118 days; P=0.195). Both categories of pregnant women with PB ≤34 wp and PB ≤32 wp showed second trimester sera Neo concentrations higher than pregnant women with BT: (7.04 vs. 6.16; P=0.126), respectively (8.92 vs. 6.16; P=0.042), however, the significance threshold was reached only for the variation of medians between the three groups, respectively, between PB≤32 wp vs. BT, but not for PB ≤34 vp vs. BT. PB was associated with an increased Neo/Cre ratio, increase which was valid for both PB ≤34 wp vs. BT (9.39 vs. 7.53; P=0.031) and PB≤32 wp vs. BT (12.10 vs. 7.53; P=0.009). No significant differences were observed regarding the CRP and Chito between the three groups or between pairs of two separately studied sub-groups. The detailed comparison of the studied parameters, stratified by the outcome of the birth status is presented in Table I.

Table I

Comparison of inflammatory marker concentration between the studied sub-groups.

Table I

Comparison of inflammatory marker concentration between the studied sub-groups.

 BTPB <34 wpPB <32 wpP-valueP-valueP-value
Variables(Group A)(Group B)(Group C)(A vs. B vs. C)(A vs. B)(A vs. C)
AOP (days)     120(7)     119(12)     118(10)     0.455     0.882     0.195
Neo (nmol/l)     6.16 (1.99)     7.04 (4.58)     8.92 (7.39)     0.046a     0.126     0.042a
CRP (mg/l)     4.0 (5.0)     3.0 (3.0)     4.0 (3.0)     0.853     0.640     0.693
Neo/Cre     7.53 (2.77)     9.39 (5.41)     12.10 (7.75)     0.008a     0.031a     0.009a
Chito (nmol/l)     27.3 (23.3)     24.0 (13.6)     26.4 (29.6)     0.890     0.807     0.670

[i] Results are presented as median and interquartile range.

[ii] aDifferences between groups are significant at α=0.05 threshold. wp, week of pregnancy; BT, birth at term; PB, preterm birth; AOP, age of pregnancy; Neo, neopterin; CRP, C-reactive protein; Neo/Cre, neopterin/creatinine; Chito, chitotriosidase.

Association between IM (Neo, Neo/Cre ratio, CRP and Chito) concentration in second trimester sera and gestational age at birth

Of the 45 pregnant women with BT, 4 women had a Neo concentration of >9 nmol/l while in the SPB group≤34 wp 5 out of 15 (OR=5.13; P=0.035) and in the SPB group ≤32 wp 5 out of 9 pregnant women showed a Neo concentration >9 nmol/l (OR=8.2; P=0.020). Neo/Cre ratio was shown to be better associated to PB than Neo. Eight out of 45 pregnant women with BT and 8 out of 15 pregnant women with SPB ≤34 wp (OR=5.29; P=0.015), respectively, 6 from 9 pregnant women with SPB ≤32 wp (OR=9.25, P=0.006) showed a Neo/Cre ratio concentration of >9.3. Since CRP and Chito showed similar concentrations in the three categories of pregnant women (BT, PB ≤34 and PB ≤32 wp), no association between PB and CRP, respectively, or Chito concentration in sera of second trimester pregnant women was found.

To evaluate the impact of the increase in the values of IM (considered as continuous variables) on the outcome of the pregnancy (considered as a dichotomous variable) we built univariate logistic regression models having as a dependent variable the PB, respectively, independent variables the serum IM levels. According to these models, we observed that increases in the levels of Neo and Neo/Cre ratio were associated with a significant increase of the odds for PB: for each increase with 1 nmol/l in Neo value the odds for PB increases with 32.1% compared with the previous odds (OR=1.321; P=0.048), respectively, for each increase with 1 unit in the Neo/Cre ratio the odds for PB increases with 22.2% (OR=1.222; P=0.041). No significant associations were found between the odds for developing PB and CRP values (OR=1.005; P=0.818) or Chito values (OR=1.000; P=0.982).

Discussion

This is the first study comparing the course of IM (Neo, Neo/Cre ratio, CRP and Chito) concentration in the first half of pregnancy of pregnant women with BT and PB and analyzes the association between PB and these IM concentrations in sera sampled 8-12 weeks before PB occurs. Our study adds to other studies that analyze IM in late pregnancy or at the time of threatened preterm labour and birth (7-11) and confirms that normal pregnancy is associated with a weak activation of the cellular immune system and with a more intense immune activation in pregnant women with PB (5,8). The strongest correlation of gestational age was found with Neo/Cre ratio, succeeded by Neo and CRP concentration. Chito did not show any correlation with gestational age, while in the PB group CRP correlated with the gestational age, but the correlation did not reach a significant threshold. We do not have an explanation as to why CRP does not correlate with GA in PB patients. We suppose that since the correlation between GA and CRP was weaker and the number of cases smaller in this group, the correlation was not sufficiently strong to reach a significant value.

Our results showed that in early pregnancy Neo better correlates with gestational age and it is a more precise marker of inflammatory changes than CRP. Since Neo is excreted without metabolisation via kidney we expected that Neo/Cre ratio may be a better marker of inflammatory changes than Neo alone (19). Our results confirm this assumption and are in concordance with observations in graft recipients where Neo/Cre ratio had a better power of prediction of graft survival than Neo alone (19).

CRP is an IM produced by the liver upon stimulation with IL-6 while Neo is produced by monocytes/macrophages upon stimulation with interferon-γ. Monocytes/macrophages are important players at the materno-fetal interface and have an implication in implantation, tissue configuration and placental disorders (8,22,23). Therefore changes at the materno-fetal interface could involve monocyte/macrophage activation and release of Neo. Also, monocytes/macrophages are involved in the initiation and maintenance of inflammation. It is known that inflammatory changes at the level of the myometrium could determine myometrium contraction and preterm labour (8,33-36). Infectious and non-infectious factors could trigger inflammation mechanisms at the materno-fetal interface (37). Lee et al (38-40) suggested that activation of the maternal immune system could play an important role in the pathogenesis of premature birth and that in certain situations the immunological reaction could be compared with a materno-fetal rejection. Immunological changes begin before clinical symptoms occur. Relying on sera collected in early pregnancy we have the opportunity to evaluate the IM concentration in pregnant women with BT and PB, 8-12 weeks before PB occurs (41). Our results reveal that only Neo and Neo/Cre ratio, but not CRP and Chito showed elevated concentrations in second trimester sera of pregnant women with PB ≤34 wp and ≤32 wp compared with those with BT.

Neo/Cre ratio and Neo concentrations in early second trimester showed the best association with PB whereas CRP and Chito concentrations showed no association. The results are in line with our previous studies that showed that early pregnancy Neo serum concentration predicts PB (5) and with other studies that showed CRP is not elevated in pregnant women with threatened preterm labor (8). Interestingly, while the study of Keskin et al (8) showed only a small increase of Chito concentration in pregnant women with threatened preterm labour compared with pregnant women with BT, our results showed no difference between the early second trimester sera Chito concentration in pregnant women with PB and BT. An explanation could be that the Chito concentration increases only at the time of, or shortly, before the threatened preterm labor.

Increased Neo values do not automatically imply immunological changes at the materno-fetal interface and must be considered as a sign of inflammation in the body. Complementary investigations should be undertaken to clarify the differential diagnosis. Such an approach may be solved in prospective studies that should evaluate the predictive value of Neo and Neo/Cre ratio in carefully selected cohorts of patients according to the etiology of PB.

In conclusion, our study provides evidence that in early pregnancy gestational age correlates with an increase in IM concentration of Neo, CRP and Neo/Cre ratio, but not of Chito. Only increased Neo and Neo/Cre ratio are associated with an increased risk of PB.

Acknowledgements

DBN would like to thank Tecan GmbH for offering the ELISA reader that was used for the relevant measurements and Astraia GmbH for offering the database software that was used for data storage.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Authors' contributions

DBN, DLS and PT wrote the manuscript. BT and ZC performed the statistical analysis of the data and contributed in the writing of the manuscript. DBN and REB performed the experiments. FB was responsible for the chitriosidase determination. MLC, RV, DN, REB and OC drafted the manuscript and revised it critically for important intellectual content. DN, DLS, PT, MLC, OC and RV were involved in the conception of the study and data interpretation. All authors read and approved the final version of the manuscript.

Ethics approval and consent to participate

The study meets the ethical guidelines, including adherence to the legal requirements of the study country. Informed consent was obtained from each patient. The study was approved by the Institutional Board of the ‘Victor Babes’ University of Medicine and Pharmacy (Timisoara, Romania) (approval no. 848/06.04.2011).

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Grebe SO and Mueller TF: Immune monitoring in organ transplantation using neopterin. Curr Drug Metab. 3:189–202. 2002.PubMed/NCBI View Article : Google Scholar

2 

Murr C, Widner B, Wirleitner B and Fuchs D: Neopterin as a marker for immune system activation. Curr Drug Metab. 3:175–187. 2002.PubMed/NCBI View Article : Google Scholar

3 

Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D and Brandacher G: Neopterin, a prognostic marker in human malignancies. Cancer Lett. 287:13–22. 2010.PubMed/NCBI View Article : Google Scholar

4 

Creţu OM, Huţ EF, Dan RG, Sima LV, Blidişel CIA, Lighezan DF, Munteanu M and Raţiu IM: Modified Whipple-Child pancreaticoduodenectomy with anastomosis on jejunal loop in continuity. Presentation of surgical technique and preliminary observations on 45 patients. Rom J Morphol Embryol. 58:1295–1299. 2017.PubMed/NCBI

5 

Navolan DB, Vladareanu S, Lahdou I, Ciohat I, Kleist C, Grigoras D, Vladareanu R, Terness P and Sas I: Early pregnancy serum neopterin concentrations predict spontaneous preterm birth in asymptomatic pregnant women. J Perinat Med. 44:517–522. 2016.PubMed/NCBI View Article : Google Scholar

6 

Burns DN, Nourjah P, Wright DJ, Minkoff H, Landesman S, Rubinstein A, Goedert JJ and Nugent RP: Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol. 42:147–165. 1999.PubMed/NCBI View Article : Google Scholar

7 

Ho M, Faye-Petersen OM, Goldenberg RL, Carlo WA, Cliver SP and Andrews WW: Elevated midtrimester α-fetoprotein and delivery markers of inflammation in a preterm population. J Matern Fetal Neonatal Med. 25:2424–2427. 2012.PubMed/NCBI View Article : Google Scholar

8 

Keskin U, Ulubay M, Kurt YG, Fidan U, Koçyiğit YK, Honca T, Aydin FN and Ergün A: Increased neopterin level and chitotriosidase activity in pregnant women with threatened preterm labor. J Matern Fetal Neonatal Med. 28:1077–1081. 2015.PubMed/NCBI View Article : Google Scholar

9 

MacIntyre DA, Sykes L, Teoh TG and Bennett PR: Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med. 25 (Suppl 1):17–20. 2012.PubMed/NCBI View Article : Google Scholar

10 

Manolea MM, Dijmărescu AL, Popescu FC, Novac MB and DiŢescu D: Evaluation of the implantation site morphology in spontaneous abortion. Rom J Morphol Embryol. 56:125–131. 2015.PubMed/NCBI

11 

Park CW, Yoon BH, Park JS and Jun JK: An elevated maternal serum C-reactive protein in the context of intra-amniotic inflammation is an indicator that the development of amnionitis, an intense fetal and AF inflammatory response are likely in patients with preterm labor: Clinical implications. J Matern Fetal Neonatal Med. 26:847–853. 2013.PubMed/NCBI View Article : Google Scholar

12 

Ozler A, Turgut A, Sak ME, Evsen MS, Soydinc HE, Evliyaoglu O and Gul T: Serum levels of neopterin, tumor necrosis factor-alpha and interleukin-6 in preeclampsia: Relationship with disease severity. Eur Rev Med Pharmacol Sci. 16:1707–1712. 2012.PubMed/NCBI

13 

Fuchs D, Weiss G and Wachter H: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 101:1–6. 1993.PubMed/NCBI View Article : Google Scholar

14 

Berdowska A and Zwirska-Korczala K: Neopterin measurement in clinical diagnosis. J Clin Pharm Ther. 26:319–329. 2001.PubMed/NCBI View Article : Google Scholar

15 

Yadav AK, Sharma V and Jha V: Association between serum neopterin and inflammatory activation in chronic kidney disease. Mediators Inflamm. 2012(476979)2012.PubMed/NCBI View Article : Google Scholar

16 

Eisenhut M: Neopterin in diagnosis and monitoring of infectious diseases. J Biomark. 2013(196432)2013.PubMed/NCBI View Article : Google Scholar

17 

Chin GK, Adams CL, Carey BS, Shaw S, Tse WY and Kaminski ER: The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection. Clin Exp Immunol. 152:239–244. 2008.PubMed/NCBI View Article : Google Scholar

18 

Carey BS, Jain R, Adams CL, Wong KY, Shaw S, Tse WY and Kaminski ER: Serum neopterin as an indicator of increased risk of renal allograft rejection. Transpl Immunol. 28:81–85. 2013.PubMed/NCBI View Article : Google Scholar

19 

Hacini J, Berthoux P, Guerin C, Charrere G, Ville G and Berthoux FC: Monitoring of renal grafts. Value of the determination of serum neopterin and neopterin versus creatinine ratio. Presse Med. 18:1913–1916. 1989.PubMed/NCBI(In French).

20 

Malaguarnera L, Barone R, Angius A and Musumeci S: Chitotriosidase, a prematurely orphan enzyme. Hum Evol. 19:71–75. 2004. View Article : Google Scholar

21 

Kanneganti M, Kamba A and Mizoguchi E: Role of chito triosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol. 5:1–9. 2012.PubMed/NCBI View Article : Google Scholar

22 

Abrahams VM, Kim YM, Straszewski SL, Romero R and Mor G: Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol. 51:275–282. 2004.PubMed/NCBI View Article : Google Scholar

23 

Madazli R, Kucur M, Gezer A, Isman F and Bulut B: Chitotriosidase and YKL-40 in normal and pre-eclamptic pregnancies. Int J Gynaecol Obstet. 100:239–243. 2008.PubMed/NCBI View Article : Google Scholar

24 

Podzimek S, Jaroslav M, Tatjana I and Duskova J: C-reactive protein in peripheral blood of patients with chronic and aggressive periodontitis. Gingivitis, and gingival recessions. Mediators Inflamm. 2015(564858)2015.PubMed/NCBI View Article : Google Scholar

25 

Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340:448–454. 1999.PubMed/NCBI View Article : Google Scholar

26 

Ferguson KK, McElrath TF, Chen YH, Mukherjee B and Meeker JD: Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol. 72:326–336. 2014.PubMed/NCBI View Article : Google Scholar

27 

Smith EJ, Muller CL, Sartorius JA, White DR and Maslow AS: C-reactive protein as a predictor of chorioamnionitis. J Am Osteopath Assoc. 112:660–664. 2012.PubMed/NCBI View Article : Google Scholar

28 

Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, et al: The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: A role for interleukin-10. J Matern Fetal Neonatal Med. 21:529–547. 2008.PubMed/NCBI View Article : Google Scholar

29 

Chan RL: Biochemical markers of spontaneous preterm birth in asymptomatic women. BioMed Res Int. 2014(164081)2014.PubMed/NCBI View Article : Google Scholar

30 

Di Renzo GC and Roura LC: European Association of Perinatal Medicine-Study Group on Preterm Birth. Guidelines for the management of spontaneous preterm labor. J Perinat Med. 34:359–366. 2006.PubMed/NCBI View Article : Google Scholar

31 

Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, et al: Guidelines for the management of spontaneous preterm labor: Identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 24:659–667. 2011.PubMed/NCBI View Article : Google Scholar

32 

Howson CP, Kinney MV, McDougall L and Lawn JE: Born Too Soon Preterm Birth Action Group. Born too soon: preterm birth matters. Reprod Health. 10 (Suppl. 1)(3828581)2013.PubMed/NCBI View Article : Google Scholar

33 

Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, Greer IA and Norman JE: Leukocytes infiltrate the myometrium during human parturition: Further evidence that labour is an inflammatory process. Hum Reprod. 14:229–236. 1999.PubMed/NCBI

34 

Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA and Norman JE: Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 9:41–45. 2003. View Article : Google Scholar

35 

Hamilton S, Oomomian Y, Stephen G, Shynlova O, Tower CL, Garrod A, Lye SJ and Jones RL: Macrophages infiltrate the human and rat decidua during term and preterm labor: Evidence that decidual inflammation precedes labor. Biol Reprod. 86(39)2012.PubMed/NCBI View Article : Google Scholar

36 

Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA and Nien JK: Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 11:317–326. 2006.PubMed/NCBI View Article : Google Scholar

37 

Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, Dong Z, Ahmed AI, Yoon BH, Hassan SS, et al: Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 72:458–474. 2014.PubMed/NCBI View Article : Google Scholar

38 

Lee J, Romero R, Xu Y, Miranda J, Yoo W, Chaemsaithong P, Kusanovic JP, Chaiworapongsa T, Tarca AL, Korzeniewski SJ, et al: Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery. Am J Reprod Immunol. 70:162–175. 2013.PubMed/NCBI View Article : Google Scholar

39 

Lee J, Romero R, Xu Y, Kim JS, Park JY, Kusanovic JP, Chaiworapongsa T, Hassan SS and Kim CJ: Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: Evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol. 66:510–526. 2011.PubMed/NCBI View Article : Google Scholar

40 

Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, Kusanovic JP, Chaiworapongsa T, Hassan SS, Yoon BH and Kim CJ: A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One. 6(e16806)2011.PubMed/NCBI View Article : Google Scholar

41 

Navolan D, Ciohat I, Dragoi V, Constantinescu S, Badiu D, Timar R, Onofriescu M, Denk R and Vladareanu R: Establishment of a Romanian database and biological sample collection for antenatal research. Gineco.eu. 9:80–82. 2013.

Related Articles

Journal Cover

September-2020
Volume 20 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Navolan DB, Stoian DL, Bohiltea RE, Crainiceanu Z, Craina ML, Cretu O, Timar B, Vladareanu R, Terness P, Būrger F, Būrger F, et al: Comparison of early pregnancy serum concentration of neopterin, neopterin/creatinine ratio, C‑reactive protein, and chitotriosidase, in pregnant women with birth at term and spontaneous preterm birth . Exp Ther Med 20: 2449-2454, 2020
APA
Navolan, D.B., Stoian, D.L., Bohiltea, R.E., Crainiceanu, Z., Craina, M.L., Cretu, O. ... Nemescu, D. (2020). Comparison of early pregnancy serum concentration of neopterin, neopterin/creatinine ratio, C‑reactive protein, and chitotriosidase, in pregnant women with birth at term and spontaneous preterm birth . Experimental and Therapeutic Medicine, 20, 2449-2454. https://doi.org/10.3892/etm.2020.8784
MLA
Navolan, D. B., Stoian, D. L., Bohiltea, R. E., Crainiceanu, Z., Craina, M. L., Cretu, O., Timar, B., Vladareanu, R., Terness, P., Būrger, F., Nemescu, D."Comparison of early pregnancy serum concentration of neopterin, neopterin/creatinine ratio, C‑reactive protein, and chitotriosidase, in pregnant women with birth at term and spontaneous preterm birth ". Experimental and Therapeutic Medicine 20.3 (2020): 2449-2454.
Chicago
Navolan, D. B., Stoian, D. L., Bohiltea, R. E., Crainiceanu, Z., Craina, M. L., Cretu, O., Timar, B., Vladareanu, R., Terness, P., Būrger, F., Nemescu, D."Comparison of early pregnancy serum concentration of neopterin, neopterin/creatinine ratio, C‑reactive protein, and chitotriosidase, in pregnant women with birth at term and spontaneous preterm birth ". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2449-2454. https://doi.org/10.3892/etm.2020.8784